nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxycodone—CYP3A5—Sulfasalazine—ankylosing spondylitis	0.125	0.192	CbGbCtD
Oxycodone—CYP3A7—Dexamethasone—ankylosing spondylitis	0.0835	0.128	CbGbCtD
Oxycodone—CYP3A7-CYP3A51P—Dexamethasone—ankylosing spondylitis	0.0835	0.128	CbGbCtD
Oxycodone—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0645	0.0987	CbGbCtD
Oxycodone—CYP3A5—Dexamethasone—ankylosing spondylitis	0.0626	0.0958	CbGbCtD
Oxycodone—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0489	0.0748	CbGbCtD
Oxycodone—CYP3A4—Betamethasone—ankylosing spondylitis	0.042	0.0642	CbGbCtD
Oxycodone—CYP3A4—Prednisolone—ankylosing spondylitis	0.0414	0.0633	CbGbCtD
Oxycodone—CYP3A4—Prednisone—ankylosing spondylitis	0.0391	0.0598	CbGbCtD
Oxycodone—CYP2D6—Dexamethasone—ankylosing spondylitis	0.0384	0.0587	CbGbCtD
Oxycodone—CYP3A4—Dexamethasone—ankylosing spondylitis	0.0244	0.0373	CbGbCtD
Oxycodone—Naloxone—TLR4—ankylosing spondylitis	0.0111	1	CrCbGaD
Oxycodone—Vertigo—Dexamethasone—ankylosing spondylitis	0.000399	0.00119	CcSEcCtD
Oxycodone—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.000399	0.00119	CcSEcCtD
Oxycodone—Syncope—Betamethasone—ankylosing spondylitis	0.000399	0.00119	CcSEcCtD
Oxycodone—Syncope—Dexamethasone—ankylosing spondylitis	0.000399	0.00119	CcSEcCtD
Oxycodone—Infection—Triamcinolone—ankylosing spondylitis	0.000397	0.00118	CcSEcCtD
Oxycodone—Sweating—Methotrexate—ankylosing spondylitis	0.000397	0.00118	CcSEcCtD
Oxycodone—Infection—Methylprednisolone—ankylosing spondylitis	0.000396	0.00118	CcSEcCtD
Oxycodone—Haematuria—Methotrexate—ankylosing spondylitis	0.000395	0.00118	CcSEcCtD
Oxycodone—Shock—Triamcinolone—ankylosing spondylitis	0.000393	0.00117	CcSEcCtD
Oxycodone—Insomnia—Prednisolone—ankylosing spondylitis	0.000393	0.00117	CcSEcCtD
Oxycodone—Shock—Methylprednisolone—ankylosing spondylitis	0.000392	0.00117	CcSEcCtD
Oxycodone—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.000392	0.00117	CcSEcCtD
Oxycodone—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000391	0.00117	CcSEcCtD
Oxycodone—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.000391	0.00117	CcSEcCtD
Oxycodone—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.000391	0.00117	CcSEcCtD
Oxycodone—Epistaxis—Methotrexate—ankylosing spondylitis	0.00039	0.00116	CcSEcCtD
Oxycodone—Paraesthesia—Prednisolone—ankylosing spondylitis	0.00039	0.00116	CcSEcCtD
Oxycodone—Tachycardia—Triamcinolone—ankylosing spondylitis	0.00039	0.00116	CcSEcCtD
Oxycodone—Mental disorder—Prednisone—ankylosing spondylitis	0.00039	0.00116	CcSEcCtD
Oxycodone—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.000389	0.00116	CcSEcCtD
Oxycodone—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000387	0.00116	CcSEcCtD
Oxycodone—Malnutrition—Prednisone—ankylosing spondylitis	0.000387	0.00115	CcSEcCtD
Oxycodone—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.000387	0.00115	CcSEcCtD
Oxycodone—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.000386	0.00115	CcSEcCtD
Oxycodone—Convulsion—Betamethasone—ankylosing spondylitis	0.000385	0.00115	CcSEcCtD
Oxycodone—Convulsion—Dexamethasone—ankylosing spondylitis	0.000385	0.00115	CcSEcCtD
Oxycodone—Myalgia—Dexamethasone—ankylosing spondylitis	0.000378	0.00113	CcSEcCtD
Oxycodone—Myalgia—Betamethasone—ankylosing spondylitis	0.000378	0.00113	CcSEcCtD
Oxycodone—Anxiety—Dexamethasone—ankylosing spondylitis	0.000377	0.00113	CcSEcCtD
Oxycodone—Anxiety—Betamethasone—ankylosing spondylitis	0.000377	0.00113	CcSEcCtD
Oxycodone—Discomfort—Dexamethasone—ankylosing spondylitis	0.000374	0.00112	CcSEcCtD
Oxycodone—Discomfort—Betamethasone—ankylosing spondylitis	0.000374	0.00112	CcSEcCtD
Oxycodone—Haemoglobin—Methotrexate—ankylosing spondylitis	0.000374	0.00111	CcSEcCtD
Oxycodone—Hypotension—Methylprednisolone—ankylosing spondylitis	0.000373	0.00111	CcSEcCtD
Oxycodone—Pain—Prednisolone—ankylosing spondylitis	0.000372	0.00111	CcSEcCtD
Oxycodone—Haemorrhage—Methotrexate—ankylosing spondylitis	0.000372	0.00111	CcSEcCtD
Oxycodone—Hepatitis—Methotrexate—ankylosing spondylitis	0.000372	0.00111	CcSEcCtD
Oxycodone—Pharyngitis—Methotrexate—ankylosing spondylitis	0.000369	0.0011	CcSEcCtD
Oxycodone—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.000367	0.00109	CcSEcCtD
Oxycodone—Urethral disorder—Methotrexate—ankylosing spondylitis	0.000364	0.00109	CcSEcCtD
Oxycodone—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000364	0.00109	CcSEcCtD
Oxycodone—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000363	0.00108	CcSEcCtD
Oxycodone—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.000363	0.00108	CcSEcCtD
Oxycodone—Oedema—Dexamethasone—ankylosing spondylitis	0.000363	0.00108	CcSEcCtD
Oxycodone—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.000363	0.00108	CcSEcCtD
Oxycodone—Oedema—Betamethasone—ankylosing spondylitis	0.000363	0.00108	CcSEcCtD
Oxycodone—Insomnia—Triamcinolone—ankylosing spondylitis	0.000362	0.00108	CcSEcCtD
Oxycodone—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000361	0.00108	CcSEcCtD
Oxycodone—Infection—Betamethasone—ankylosing spondylitis	0.00036	0.00108	CcSEcCtD
Oxycodone—Infection—Dexamethasone—ankylosing spondylitis	0.00036	0.00108	CcSEcCtD
Oxycodone—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.000359	0.00107	CcSEcCtD
Oxycodone—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000359	0.00107	CcSEcCtD
Oxycodone—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000358	0.00107	CcSEcCtD
Oxycodone—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000358	0.00107	CcSEcCtD
Oxycodone—Visual impairment—Methotrexate—ankylosing spondylitis	0.000358	0.00107	CcSEcCtD
Oxycodone—Anaemia—Prednisone—ankylosing spondylitis	0.000358	0.00107	CcSEcCtD
Oxycodone—Shock—Dexamethasone—ankylosing spondylitis	0.000357	0.00106	CcSEcCtD
Oxycodone—Shock—Betamethasone—ankylosing spondylitis	0.000357	0.00106	CcSEcCtD
Oxycodone—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000356	0.00106	CcSEcCtD
Oxycodone—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000356	0.00106	CcSEcCtD
Oxycodone—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000356	0.00106	CcSEcCtD
Oxycodone—Agitation—Prednisone—ankylosing spondylitis	0.000356	0.00106	CcSEcCtD
Oxycodone—Tachycardia—Betamethasone—ankylosing spondylitis	0.000354	0.00106	CcSEcCtD
Oxycodone—Tachycardia—Dexamethasone—ankylosing spondylitis	0.000354	0.00106	CcSEcCtD
Oxycodone—Angioedema—Prednisone—ankylosing spondylitis	0.000354	0.00106	CcSEcCtD
Oxycodone—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000352	0.00105	CcSEcCtD
Oxycodone—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000351	0.00105	CcSEcCtD
Oxycodone—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.000351	0.00105	CcSEcCtD
Oxycodone—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.000351	0.00105	CcSEcCtD
Oxycodone—Malaise—Prednisone—ankylosing spondylitis	0.000349	0.00104	CcSEcCtD
Oxycodone—Vertigo—Prednisone—ankylosing spondylitis	0.000348	0.00104	CcSEcCtD
Oxycodone—Eye disorder—Methotrexate—ankylosing spondylitis	0.000347	0.00104	CcSEcCtD
Oxycodone—Syncope—Prednisone—ankylosing spondylitis	0.000347	0.00104	CcSEcCtD
Oxycodone—Tinnitus—Methotrexate—ankylosing spondylitis	0.000347	0.00103	CcSEcCtD
Oxycodone—Anorexia—Betamethasone—ankylosing spondylitis	0.000346	0.00103	CcSEcCtD
Oxycodone—Anorexia—Dexamethasone—ankylosing spondylitis	0.000346	0.00103	CcSEcCtD
Oxycodone—Urticaria—Prednisolone—ankylosing spondylitis	0.000345	0.00103	CcSEcCtD
Oxycodone—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.000345	0.00103	CcSEcCtD
Oxycodone—Fatigue—Triamcinolone—ankylosing spondylitis	0.000345	0.00103	CcSEcCtD
Oxycodone—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000344	0.00103	CcSEcCtD
Oxycodone—Pain—Triamcinolone—ankylosing spondylitis	0.000342	0.00102	CcSEcCtD
Oxycodone—Loss of consciousness—Prednisone—ankylosing spondylitis	0.00034	0.00102	CcSEcCtD
Oxycodone—Hypotension—Betamethasone—ankylosing spondylitis	0.000339	0.00101	CcSEcCtD
Oxycodone—Hypotension—Dexamethasone—ankylosing spondylitis	0.000339	0.00101	CcSEcCtD
Oxycodone—Angiopathy—Methotrexate—ankylosing spondylitis	0.000337	0.00101	CcSEcCtD
Oxycodone—Immune system disorder—Methotrexate—ankylosing spondylitis	0.000336	0.001	CcSEcCtD
Oxycodone—Convulsion—Prednisone—ankylosing spondylitis	0.000335	0.001	CcSEcCtD
Oxycodone—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.000335	0.000999	CcSEcCtD
Oxycodone—Chills—Methotrexate—ankylosing spondylitis	0.000333	0.000995	CcSEcCtD
Oxycodone—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000331	0.000986	CcSEcCtD
Oxycodone—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000331	0.000986	CcSEcCtD
Oxycodone—Arthralgia—Prednisone—ankylosing spondylitis	0.00033	0.000983	CcSEcCtD
Oxycodone—Myalgia—Prednisone—ankylosing spondylitis	0.00033	0.000983	CcSEcCtD
Oxycodone—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000329	0.000983	CcSEcCtD
Oxycodone—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000329	0.000981	CcSEcCtD
Oxycodone—Anxiety—Prednisone—ankylosing spondylitis	0.000328	0.00098	CcSEcCtD
Oxycodone—Insomnia—Betamethasone—ankylosing spondylitis	0.000328	0.000979	CcSEcCtD
Oxycodone—Insomnia—Dexamethasone—ankylosing spondylitis	0.000328	0.000979	CcSEcCtD
Oxycodone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000327	0.000976	CcSEcCtD
Oxycodone—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000326	0.000973	CcSEcCtD
Oxycodone—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000326	0.000972	CcSEcCtD
Oxycodone—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000326	0.000972	CcSEcCtD
Oxycodone—Discomfort—Prednisone—ankylosing spondylitis	0.000326	0.000971	CcSEcCtD
Oxycodone—Mental disorder—Methotrexate—ankylosing spondylitis	0.000326	0.000971	CcSEcCtD
Oxycodone—Malnutrition—Methotrexate—ankylosing spondylitis	0.000324	0.000965	CcSEcCtD
Oxycodone—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.00032	0.000956	CcSEcCtD
Oxycodone—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000319	0.000953	CcSEcCtD
Oxycodone—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000319	0.000953	CcSEcCtD
Oxycodone—Urticaria—Triamcinolone—ankylosing spondylitis	0.000318	0.000948	CcSEcCtD
Oxycodone—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000317	0.000945	CcSEcCtD
Oxycodone—Dysgeusia—Methotrexate—ankylosing spondylitis	0.000317	0.000945	CcSEcCtD
Oxycodone—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000316	0.000943	CcSEcCtD
Oxycodone—Oedema—Prednisone—ankylosing spondylitis	0.000316	0.000943	CcSEcCtD
Oxycodone—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.000316	0.000943	CcSEcCtD
Oxycodone—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000315	0.000941	CcSEcCtD
Oxycodone—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000315	0.000941	CcSEcCtD
Oxycodone—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000315	0.000941	CcSEcCtD
Oxycodone—Infection—Prednisone—ankylosing spondylitis	0.000314	0.000936	CcSEcCtD
Oxycodone—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000313	0.000934	CcSEcCtD
Oxycodone—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000313	0.000934	CcSEcCtD
Oxycodone—Back pain—Methotrexate—ankylosing spondylitis	0.000313	0.000934	CcSEcCtD
Oxycodone—Fatigue—Dexamethasone—ankylosing spondylitis	0.000313	0.000933	CcSEcCtD
Oxycodone—Fatigue—Betamethasone—ankylosing spondylitis	0.000313	0.000933	CcSEcCtD
Oxycodone—Shock—Prednisone—ankylosing spondylitis	0.000311	0.000927	CcSEcCtD
Oxycodone—Pain—Dexamethasone—ankylosing spondylitis	0.00031	0.000926	CcSEcCtD
Oxycodone—Pain—Betamethasone—ankylosing spondylitis	0.00031	0.000926	CcSEcCtD
Oxycodone—Nervous system disorder—Prednisone—ankylosing spondylitis	0.00031	0.000924	CcSEcCtD
Oxycodone—Tachycardia—Prednisone—ankylosing spondylitis	0.000308	0.00092	CcSEcCtD
Oxycodone—Skin disorder—Prednisone—ankylosing spondylitis	0.000307	0.000915	CcSEcCtD
Oxycodone—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.000305	0.000911	CcSEcCtD
Oxycodone—Anorexia—Prednisone—ankylosing spondylitis	0.000301	0.000898	CcSEcCtD
Oxycodone—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.0003	0.000896	CcSEcCtD
Oxycodone—Anaemia—Methotrexate—ankylosing spondylitis	0.000299	0.000892	CcSEcCtD
Oxycodone—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000299	0.000892	CcSEcCtD
Oxycodone—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000299	0.000892	CcSEcCtD
Oxycodone—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000297	0.000885	CcSEcCtD
Oxycodone—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000297	0.000885	CcSEcCtD
Oxycodone—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000295	0.000879	CcSEcCtD
Oxycodone—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000294	0.000877	CcSEcCtD
Oxycodone—Malaise—Methotrexate—ankylosing spondylitis	0.000292	0.00087	CcSEcCtD
Oxycodone—Vertigo—Methotrexate—ankylosing spondylitis	0.000291	0.000867	CcSEcCtD
Oxycodone—Leukopenia—Methotrexate—ankylosing spondylitis	0.00029	0.000864	CcSEcCtD
Oxycodone—Urticaria—Betamethasone—ankylosing spondylitis	0.000288	0.00086	CcSEcCtD
Oxycodone—Urticaria—Dexamethasone—ankylosing spondylitis	0.000288	0.00086	CcSEcCtD
Oxycodone—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000288	0.000859	CcSEcCtD
Oxycodone—Dizziness—Prednisolone—ankylosing spondylitis	0.000288	0.000858	CcSEcCtD
Oxycodone—Asthenia—Triamcinolone—ankylosing spondylitis	0.000287	0.000856	CcSEcCtD
Oxycodone—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000287	0.000856	CcSEcCtD
Oxycodone—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000287	0.000856	CcSEcCtD
Oxycodone—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000287	0.000856	CcSEcCtD
Oxycodone—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000287	0.000856	CcSEcCtD
Oxycodone—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000286	0.000854	CcSEcCtD
Oxycodone—Insomnia—Prednisone—ankylosing spondylitis	0.000286	0.000852	CcSEcCtD
Oxycodone—Paraesthesia—Prednisone—ankylosing spondylitis	0.000284	0.000846	CcSEcCtD
Oxycodone—Pruritus—Triamcinolone—ankylosing spondylitis	0.000283	0.000844	CcSEcCtD
Oxycodone—Cough—Methotrexate—ankylosing spondylitis	0.000282	0.000842	CcSEcCtD
Oxycodone—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000282	0.000842	CcSEcCtD
Oxycodone—Convulsion—Methotrexate—ankylosing spondylitis	0.00028	0.000836	CcSEcCtD
Oxycodone—Dyspepsia—Prednisone—ankylosing spondylitis	0.000278	0.00083	CcSEcCtD
Oxycodone—Myalgia—Methotrexate—ankylosing spondylitis	0.000275	0.000822	CcSEcCtD
Oxycodone—Arthralgia—Methotrexate—ankylosing spondylitis	0.000275	0.000822	CcSEcCtD
Oxycodone—Chest pain—Methotrexate—ankylosing spondylitis	0.000275	0.000822	CcSEcCtD
Oxycodone—Decreased appetite—Prednisone—ankylosing spondylitis	0.000275	0.000819	CcSEcCtD
Oxycodone—Rash—Prednisolone—ankylosing spondylitis	0.000274	0.000818	CcSEcCtD
Oxycodone—Dermatitis—Prednisolone—ankylosing spondylitis	0.000274	0.000817	CcSEcCtD
Oxycodone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000274	0.000816	CcSEcCtD
Oxycodone—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000273	0.000814	CcSEcCtD
Oxycodone—Fatigue—Prednisone—ankylosing spondylitis	0.000272	0.000813	CcSEcCtD
Oxycodone—Headache—Prednisolone—ankylosing spondylitis	0.000272	0.000813	CcSEcCtD
Oxycodone—Discomfort—Methotrexate—ankylosing spondylitis	0.000272	0.000812	CcSEcCtD
Oxycodone—Constipation—Prednisone—ankylosing spondylitis	0.00027	0.000806	CcSEcCtD
Oxycodone—Confusional state—Methotrexate—ankylosing spondylitis	0.000266	0.000794	CcSEcCtD
Oxycodone—Dizziness—Triamcinolone—ankylosing spondylitis	0.000264	0.000789	CcSEcCtD
Oxycodone—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.000264	0.000788	CcSEcCtD
Oxycodone—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000264	0.000787	CcSEcCtD
Oxycodone—Infection—Methotrexate—ankylosing spondylitis	0.000262	0.000783	CcSEcCtD
Oxycodone—Feeling abnormal—Prednisone—ankylosing spondylitis	0.00026	0.000777	CcSEcCtD
Oxycodone—Asthenia—Dexamethasone—ankylosing spondylitis	0.00026	0.000777	CcSEcCtD
Oxycodone—Asthenia—Betamethasone—ankylosing spondylitis	0.00026	0.000777	CcSEcCtD
Oxycodone—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000259	0.000772	CcSEcCtD
Oxycodone—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000258	0.000771	CcSEcCtD
Oxycodone—Nausea—Prednisolone—ankylosing spondylitis	0.000258	0.00077	CcSEcCtD
Oxycodone—Pruritus—Betamethasone—ankylosing spondylitis	0.000257	0.000766	CcSEcCtD
Oxycodone—Pruritus—Dexamethasone—ankylosing spondylitis	0.000257	0.000766	CcSEcCtD
Oxycodone—Skin disorder—Methotrexate—ankylosing spondylitis	0.000256	0.000765	CcSEcCtD
Oxycodone—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.000255	0.000761	CcSEcCtD
Oxycodone—Vomiting—Triamcinolone—ankylosing spondylitis	0.000254	0.000758	CcSEcCtD
Oxycodone—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000254	0.000757	CcSEcCtD
Oxycodone—Rash—Triamcinolone—ankylosing spondylitis	0.000252	0.000752	CcSEcCtD
Oxycodone—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000252	0.000751	CcSEcCtD
Oxycodone—Anorexia—Methotrexate—ankylosing spondylitis	0.000252	0.000751	CcSEcCtD
Oxycodone—Rash—Methylprednisolone—ankylosing spondylitis	0.000252	0.00075	CcSEcCtD
Oxycodone—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000251	0.00075	CcSEcCtD
Oxycodone—Urticaria—Prednisone—ankylosing spondylitis	0.000251	0.000749	CcSEcCtD
Oxycodone—Headache—Triamcinolone—ankylosing spondylitis	0.00025	0.000747	CcSEcCtD
Oxycodone—Headache—Methylprednisolone—ankylosing spondylitis	0.00025	0.000746	CcSEcCtD
Oxycodone—Abdominal pain—Prednisone—ankylosing spondylitis	0.00025	0.000745	CcSEcCtD
Oxycodone—Body temperature increased—Prednisone—ankylosing spondylitis	0.00025	0.000745	CcSEcCtD
Oxycodone—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000248	0.000741	CcSEcCtD
Oxycodone—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000248	0.000741	CcSEcCtD
Oxycodone—Hypotension—Methotrexate—ankylosing spondylitis	0.000247	0.000736	CcSEcCtD
Oxycodone—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000241	0.000718	CcSEcCtD
Oxycodone—Dizziness—Betamethasone—ankylosing spondylitis	0.00024	0.000716	CcSEcCtD
Oxycodone—Dizziness—Dexamethasone—ankylosing spondylitis	0.00024	0.000716	CcSEcCtD
Oxycodone—Insomnia—Methotrexate—ankylosing spondylitis	0.000239	0.000712	CcSEcCtD
Oxycodone—Nausea—Triamcinolone—ankylosing spondylitis	0.000237	0.000708	CcSEcCtD
Oxycodone—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000237	0.000707	CcSEcCtD
Oxycodone—Nausea—Methylprednisolone—ankylosing spondylitis	0.000237	0.000707	CcSEcCtD
Oxycodone—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000235	0.000702	CcSEcCtD
Oxycodone—Somnolence—Methotrexate—ankylosing spondylitis	0.000235	0.0007	CcSEcCtD
Oxycodone—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000233	0.000694	CcSEcCtD
Oxycodone—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000232	0.000693	CcSEcCtD
Oxycodone—Vomiting—Dexamethasone—ankylosing spondylitis	0.000231	0.000688	CcSEcCtD
Oxycodone—Vomiting—Betamethasone—ankylosing spondylitis	0.000231	0.000688	CcSEcCtD
Oxycodone—Decreased appetite—Methotrexate—ankylosing spondylitis	0.00023	0.000685	CcSEcCtD
Oxycodone—Rash—Dexamethasone—ankylosing spondylitis	0.000229	0.000682	CcSEcCtD
Oxycodone—Rash—Betamethasone—ankylosing spondylitis	0.000229	0.000682	CcSEcCtD
Oxycodone—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000229	0.000682	CcSEcCtD
Oxycodone—Dermatitis—Betamethasone—ankylosing spondylitis	0.000229	0.000682	CcSEcCtD
Oxycodone—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000228	0.00068	CcSEcCtD
Oxycodone—Fatigue—Methotrexate—ankylosing spondylitis	0.000228	0.000679	CcSEcCtD
Oxycodone—Headache—Dexamethasone—ankylosing spondylitis	0.000227	0.000678	CcSEcCtD
Oxycodone—Headache—Betamethasone—ankylosing spondylitis	0.000227	0.000678	CcSEcCtD
Oxycodone—Asthenia—Prednisone—ankylosing spondylitis	0.000227	0.000676	CcSEcCtD
Oxycodone—Pain—Methotrexate—ankylosing spondylitis	0.000226	0.000674	CcSEcCtD
Oxycodone—Pruritus—Prednisone—ankylosing spondylitis	0.000224	0.000667	CcSEcCtD
Oxycodone—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000218	0.000649	CcSEcCtD
Oxycodone—Diarrhoea—Prednisone—ankylosing spondylitis	0.000216	0.000645	CcSEcCtD
Oxycodone—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000216	0.000644	CcSEcCtD
Oxycodone—Nausea—Betamethasone—ankylosing spondylitis	0.000215	0.000643	CcSEcCtD
Oxycodone—Nausea—Dexamethasone—ankylosing spondylitis	0.000215	0.000643	CcSEcCtD
Oxycodone—Urticaria—Methotrexate—ankylosing spondylitis	0.00021	0.000626	CcSEcCtD
Oxycodone—Dizziness—Prednisone—ankylosing spondylitis	0.000209	0.000623	CcSEcCtD
Oxycodone—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000209	0.000623	CcSEcCtD
Oxycodone—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000209	0.000623	CcSEcCtD
Oxycodone—Vomiting—Prednisone—ankylosing spondylitis	0.000201	0.000599	CcSEcCtD
Oxycodone—Rash—Prednisone—ankylosing spondylitis	0.000199	0.000594	CcSEcCtD
Oxycodone—Dermatitis—Prednisone—ankylosing spondylitis	0.000199	0.000594	CcSEcCtD
Oxycodone—Headache—Prednisone—ankylosing spondylitis	0.000198	0.00059	CcSEcCtD
Oxycodone—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000195	0.00058	CcSEcCtD
Oxycodone—Asthenia—Methotrexate—ankylosing spondylitis	0.000189	0.000565	CcSEcCtD
Oxycodone—Nausea—Prednisone—ankylosing spondylitis	0.000188	0.00056	CcSEcCtD
Oxycodone—Pruritus—Methotrexate—ankylosing spondylitis	0.000187	0.000557	CcSEcCtD
Oxycodone—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000181	0.000539	CcSEcCtD
Oxycodone—Dizziness—Methotrexate—ankylosing spondylitis	0.000175	0.000521	CcSEcCtD
Oxycodone—Vomiting—Methotrexate—ankylosing spondylitis	0.000168	0.000501	CcSEcCtD
Oxycodone—Rash—Methotrexate—ankylosing spondylitis	0.000166	0.000497	CcSEcCtD
Oxycodone—Dermatitis—Methotrexate—ankylosing spondylitis	0.000166	0.000496	CcSEcCtD
Oxycodone—Headache—Methotrexate—ankylosing spondylitis	0.000165	0.000493	CcSEcCtD
Oxycodone—Nausea—Methotrexate—ankylosing spondylitis	0.000157	0.000468	CcSEcCtD
